|
Market Closed -
Bombay S.E.
06:02:22 2026-08-31 EDT
|
5-day change | 1st Jan Change | ||
| 371.60 INR | +4.56% |
|
+4.26% | +19.81% |
| 08-01 | SMS Pharmaceuticals Limited announces Annual dividend, payable on October 23, 2026 | CI |
| 07-31 | SMS Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Company Valuation: SMS Pharmaceuticals Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 2,277 | 10,518 | 7,915 | 4,931 | 15,089 | 18,863 |
| Change | - | 361.9% | -24.75% | -37.7% | 206.01% | 25.01% |
| Enterprise Value (EV) 1 | 3,752 | 12,660 | 10,082 | 7,398 | 17,536 | 21,556 |
| Change | - | 237.37% | -20.36% | -26.62% | 137.04% | 22.93% |
| P/E | 7.21x | 16.8x | 12.7x | -69.9x | 30.3x | 27.3x |
| PBR | 0.65x | 2.56x | 1.68x | 1.07x | 2.81x | 2.95x |
| PEG | - | 0.2x | -25.87x | 1x | -0x | 0.8x |
| Capitalization / Revenue | 0.55x | 1.86x | 1.52x | 0.94x | 2.13x | 2.41x |
| EV / Revenue | 0.91x | 2.24x | 1.94x | 1.42x | 2.47x | 2.75x |
| EV / EBITDA | 4.58x | 10.3x | 8.83x | 13.7x | 15x | 15.5x |
| EV / EBIT | 6.15x | 12.5x | 12.1x | 32.5x | 20.4x | 20.5x |
| EV / FCF | -64.8x | -12.4x | -44.8x | -23.4x | -70.3x | -31x |
| FCF Yield | -1.54% | -8.04% | -2.23% | -4.27% | -1.42% | -3.22% |
| Dividend per Share 2 | 0.25 | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 |
| Rate of return | 0.93% | 0.24% | 0.32% | 0.52% | 0.22% | 0.19% |
| EPS 2 | 3.73 | 7.386 | 7.35 | -0.8339 | 5.886 | 7.799 |
| Distribution rate | 6.7% | 4.06% | 4.08% | -36% | 6.8% | 5.13% |
| Net sales 1 | 4,146 | 5,651 | 5,199 | 5,221 | 7,093 | 7,827 |
| EBITDA 1 | 819.8 | 1,227 | 1,142 | 541.8 | 1,169 | 1,387 |
| EBIT 1 | 609.7 | 1,014 | 830.7 | 227.3 | 860.1 | 1,049 |
| Net income 1 | 315.7 | 625.3 | 622.2 | -70.59 | 498.3 | 691.4 |
| Net Debt 1 | 1,475 | 2,142 | 2,167 | 2,467 | 2,447 | 2,693 |
| Reference price 2 | 26.90 | 124.25 | 93.50 | 58.25 | 178.25 | 212.78 |
| Nbr of stocks (in thousands) | 84,652 | 84,652 | 84,652 | 84,652 | 84,652 | 88,652 |
| Announcement Date | 9/8/20 | 9/8/21 | 9/7/22 | 9/7/23 | 9/6/24 | 9/6/25 |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 35.43x | 6.66x | 23.08x | 0.89% | 48.2B | ||
| 17.52x | 2.19x | 9.9x | 1.48% | 39.97B | ||
| 28.56x | 4.06x | 16.85x | 0.57% | 12.43B | ||
| 27.71x | 3.37x | 17.45x | 0.91% | 12.03B | ||
| 19.17x | 3.41x | 11.88x | 3.76% | 9.35B | ||
| 9.79x | 2.26x | 5.85x | 4.42% | 7.75B | ||
| 30.59x | 4.01x | 18.65x | 0.15% | 7.43B | ||
| 15.85x | 2.08x | 6.73x | 3.18% | 7.22B | ||
| Average | 23.08x | 3.51x | 13.80x | 1.92% | 18.05B | |
| Weighted average by Cap. | 25.58x | 4.11x | 15.73x | 1.48% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- SMSPHARMA Stock
- SMSPHARMA Stock
- Valuation SMS Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
















